CanDrivR-CS: A Cancer-Specific Machine Learning Framework for Distinguishing Recurrent and Rare Variants
Abstract
MotivationMissense variants play a crucial role in cancer development, and distinguishing between those that frequently occur in cancer genomes and those that are rare may provide valuable insights into important functional mechanisms and consequences. Specifically, if common variants confer growth advantages, they may have undergone positive selection across different patients due to similar selection pressures. Moreover, studies have demonstrated the significance of rare mutations that arise as resistance mechanisms in response to drug treatment. This highlights the importance of understanding the role of both recurrent and rare variants in cancer. In addition to this, most existing tools for variant prediction focus on distinguishing variants found in normal and disease populations, often without considering the specific disease contexts in which these variants arise. Instead, they typically build predictors that generalise across all diseases. Here, we introduce CanDrivR-CS, a set of cancer-specific gradient boosting models designed to distinguish between rare and recurrent cancer variants. ResultsWe curated missense variant data from the International Cancer Genome Consortium (ICGC). Cancer-type-specific models significantly outperformed a baseline pan-cancer model, achieving a maximum leave-one-group-out cross-validation (LOGO-CV) F1 score of up to 90% for CanDrivRSKCM (Skin Cutaneous Melanoma) and 89% for CanDrivR-SKCA (Skin Adenocarcinoma), compared to 79.2% for the baseline model. Notably, DNA shape properties consistently ranked among the top features for distinguishing recurrent and rare variants across all cancers. Specifically, recurrent missense variants frequently occurred in DNA bends and rolls, potentially implicating regions prone to DNA replication errors and acting as mutational hotspots. Availability and ImplementationAll training and test data, and Python code are available in our CanDrivR-CS GitHub repository: https://github.com/amyfrancis97/CanDrivR-CS.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 3th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Leveraging cancer mutation data to predict the pathogenicity of germline missense variants
Bushra Haque, David Cheerie, … Gregory Costain·medRxiv·Mar 11, 2024
- An interpretable molecular framework for predicting cancer driver missense mutations
Yan Yang, Weikang Sun, … Minghui Li·Proceedings of the National Academy of SciencesPeer-reviewed·Feb 3, 2026
- CHASMplus reveals the scope of somatic missense mutations driving human cancers
Collin J. Tokheim, Rachel Karchin·Cell SystemsPeer-reviewed·Jun 12, 2019
- iDriver: A patient-centric framework for genome-wide cancer driver discovery
Farideh Bahari, Hesam Montazeri·bioRxiv·Sep 17, 2026
- Accurate Variant Classification in Tumour-Only Genomic Data Using Interpretable Tabular Models
Lorenzo Tattini, Yiqing Yan, … Raja Appuswamy·bioRxiv·Dec 12, 2025
- Finding Driver Mutations in Cancer: Elucidating the Role of Background Mutational Processes
A.-L. Brown, M. Li, … A. R. Panchenko·bioRxiv·Apr 1, 2019